Existing drug opens new possibilities for treating child leukemia
A new study from Linköping University has shown that the tumor-inhibiting gene TET2 is silenced in a large fraction of cases of acute lymphoblastic leukemia (ALL) in children. The scientists show that the gene can be reactivated by treatment with…
Read MoreReport: Musculoskeletal disorders costly for society
More money was spent on musculoskeletal disorders, such as osteoarthritis and back pain, than any other disease, condition or injury in Australia, suggests a new report from the Australian Institute of Health and Welfare (AIHW). The report, Disease expenditure in…
Read MoreStudy investigates COVID-19 vaccination during pregnancy
In one of the largest studies of its kind, scientists have concluded that COVID-19 vaccines are well-tolerated by people who are pregnant, lactating, or planning pregnancy. The study compared vaccination reactions among people who are pregnant and lactating and people…
Read MoreThese delta variant mutations may explain its scary power
Ever since the delta variant of the coronavirus exploded in India in the first half of 2021 and now around the world, researchers have been trying to understand what makes this particular SARS-CoV-2 strain so transmissible. Now, they’re narrowing down…
Read MoreBilly Connolly health latest: Comedian says Parkinson’s disease is ‘getting worse’
Billy Connolly discusses Parkinson’s and cancer diagnoses We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You…
Read MoreNumber of people living with hypertension has doubled worldwide over past 30 years to more than 1.2 billion
Over the past 30 years, the number of adults (aged 30-79 years) living with hypertension worldwide has doubled—rising from an estimated 331 million women and 317 million men in 1990, to 626 million women and 652 million men in 2019,…
Read MoreTwo studies on gastrointestinal stroma tumors describe advances that may lead to new treatments
Gastrointestinal stroma tumors (GIST) are cancers that start in specialized nerve cells found in the digestive system, from the esophagus and stomach to the intestines and rectum. They are rare, but because they often grow slowly or initially cause no…
Read MoreLarge genetic analysis identifies numerous gene variants linked with differences in food intake
A team of researchers at Massachusetts General Hospital (MGH), Boston University School of Public Health (BUSPH), and other institutions have identified more than two dozen genetic regions that may affect individuals’ food intake. The investigators hope that the discovery, which…
Read MoreAdding metformin to chemoradiation for locally advanced non-small cell lung cancer doesn’t yield survival benefits
A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology. NRG-LU001 enrolled…
Read MoreNew Pacing Method Shows Early Promise for Advanced Peripheral Conduction Disease
NEW YORK (Reuters Health) – Early results suggest that left bundle branch area pacing (LBBAP)-optimized cardiac resynchronization therapy (LOT-CRT) is feasible and safe, and offers greater electrical resynchronization compared with conventional biventricular pacing (BiV-CRT). LOT-CRT “could be an alternative option,…
Read More